This email has been funded by Tillotts Pharma and is for healthcare professionals only.

Having trouble viewing this email? View in your browser.

This email has been funded by Tillotts Pharma and is for healthcare professionals only.

An invitation to join us at the

Tillotts Pharma Integrated Symposium at ECCMID 2024

Combatting the key challenges of CDI for better patient outcomes:

an update from the COMBACTE-CDI study group

Monday 29th April 2024 | 13:30-15:30 | Hall L

This two-hour programme, chaired by Mark Wilcox, will feature engaging and topical presentations from world-renowned clinicians and researchers.

Exploring best practice in Clostridioides difficile infection (CDI), the symposium will share insights into improving patient care while examining the impact of clinical practice on real patients. For first-time infection or in recurrent infection, you may find this symposium challenges the status quo, to help deliver positive outcomes for your patients.

Programme summary

Introduction by Chair Prof Mark Wilcox, Leeds Teaching Hospitals and University of Leeds, UK and ESCMID-appointed Chair, Dr Ines B. Moura, University of Leeds, UK

Does the key to effective CDI management lie in diagnosis and testing for C. difficile?

Dr Kerrie Davies, Leeds Teaching Hospitals and University of Leeds, UK

The epidemiology of CDI: Time to think beyond the walls of the hospital

Professor Maja Rupnik, National Laboratory of Health, Environment and Food, Maribor, Slovenia

Tackling the challenge of CDI management first time and in recurrent infection

Dr Nicola Petrosillo, University Hospital Campus Bio Medico, Rome, Italy

Dr Sebastian Wingen-Heimann, University Hospital of Cologne, Male, Cologne, Germany

Dr Tim Planche, St George's University of London, UK

Time to challenge the status quo and deliver positive outcomes for our patients

Dr Elena Reigadas Ramírez, Hospital GU Gregorio Marańōn, Madrid, Spain

Become a participant

Within the symposium the faculty will include in the discussions your perspectives of actual CDI clinical practice and guideline implementation using a survey of your responses.

Your experience, perspective and practice are highly relevant and can contribute to the discussion, so to take part, visit the Tillotts Pharma booth C21.

This is an educational symposium by Tillotts Pharma for healthcare professionals only.

NP--ALL-00403-March 2024

You have received this email as a contact of ESCMID or one of its affiliated societies.
You can unsubscribe here.